In a prospective longitudinal study, Kmiecik et al. find that genotyped LRRK2 G2019S carriers report a similar burden of motor symptoms to non-carriers with Parkinson’s disease, but fewer non-motor symptoms including cognitive difficulties and hyposmia. The gene discussed is LRRK2; the disease is Parkinson disease.